LGALS8 and neoplasm: In terms of the assessment of the Gal-8 expression score in different WHO tumor subtypes, our study revealed a high Gal-8 expression in HGSC, in 88.88%; in EC, in 55.55%; in MOC, in 66.66%; and in COC, in 100% of cases.